Advocacy Lab

Europe is adopting hybrid construction methods to build housing faster, cheaper, and more sustainably. The approach is gaining traction as a solution to accelerate housing development.

Bulgaria's national children’s hospital project is at risk due to funding challenges and a severe shortage of medical staff, which experts warn could undermine it even if construction proceeds. The project is described as being on 'life support' amid these concerns.

Construction Products Europe warns that the Commission's housing demand target is 'extremely demanding' and that failing to treat the construction sector as a strategic industrial value chain could lead to costly mistakes.

Dementia experts from 12 countries have signed a policy paper urging Brussels to create a dementia strategy modeled on Europe's €4 billion Beating Cancer Plan. The initiative calls for a dedicated framework to address dementia, similar to the existing cancer plan.

Europe’s battery ambitions are struggling to achieve industrial scale, with the primary challenge now shifting from strategy development to actual delivery of battery production.

Belgium supports a coordinated European approach to address US demands on medicine pricing, while Greece advocates for accelerating biotech scale-up. The article highlights divergent EU member state strategies in responding to drug pricing pressures and biotechnology development.

Czechia urges caution on EU drug pricing amid US pressure, supporting stronger EU cooperation but insisting governments retain control over pricing and reimbursement decisions.

Bulgaria’s pharmaceutical market, described as 'overregulated,' is set for a comprehensive review by Advocacy Lab. The new government faces pressure to improve access to innovative therapies while addressing hospital debt.

Sweden plans to enhance crisis readiness for its blood and plasma system. A new inquiry will examine methods to scale up supplies during mass casualty incidents.

The EU is coordinating housing and energy policies to address a deepening poverty crisis, focusing on affordability and renovation. The Social Climate Fund's activation is approaching, prompting this action.

Biosimilars have expanded access to biologic therapies for millions of patients in the EU ten years after the first etanercept biosimilar entered the market.

The Netherlands lacks a dedicated health AI strategy, leading to legal uncertainty for hospitals. Dutch doctors encounter situations where the correct use of AI is unclear.

A national report by Advocacy Lab warns that Swedes are not receiving effective obesity care. The report emphasizes the importance of primary care in addressing obesity to ensure timely patient support.